Document Page: First | Prev | Next | All | Image | This Release | Search

F~GE C)2 RHIF~~~3414 UNLL~;S
    M~NY YE~RS OF USE IN HUM~NS FOR NuN-MlLI~~k..Y FURFOSES INDIL~TES
TH~T FYRiDOSTIGMINE 15 S~FE ~ND FREE FROM DE~ILIT~TING SIDE EFFEC~S
IF USED ~~ RECOMMENDED.   IT IS NOT ~N *sEXPERIMENT~Lsl DRUG.  DOS~GE
-IS ONE (1) r~ MG T~BLET EVERY EIGHT (8) HOURS.   IF ~ DOSE IS MISSED,
DO NOT - REPE~T DO NOT, T~KE TWO T~E(LETS ~T ONCE - MERELY ST~RT
~G~IN WITH ONE T~BLET EVERY EIGHT HOURS. T~KING MORE TH~N ONE T~~LET
   ~ TIME DOES NOT FROVIDE ~NY (iDDITION~L FROTECTION ~ND M~Y ~E
H~Z~RDOUS.
4.  THE CHEMIC~L THRE~T, ~ND NEED. TO CONTINUE N~FF', SHOULD BE
REEV~LU~TED EVERY THREE D~YS ~T ~ MINIMUM.   THERE ~RE NO
CONTR~INDIC~TIONS TO REFE~TED ST~RTS ~ND STOFS OF N~PF'
~DMINISTR~TION, BUT DECISION TO DO SO SHOULD BE B~SED ON THRE~T
~SSESSMENT ~ND T~CTIC~L SITU~TION.  ~DMINISTR~TION BEYOND 21 D~YS
IS NOT RECOMMENDED WITHOUT fl THOROUGH EV~LU~TION OF THE SITU~TION.
5.  FOC ~T USCENTCOM CCSG IS LTC W~DE, T~C 9-8v6---7~9, COMMERCI~L
C)11-96~-1-478-4466 EXT llC).//

.~ ~5:t~76

Document Page: First | Prev | Next | All | Image | This Release | Search